Lung cancer remains the leading cause of cancer death worldwide. According to the World Health Organization, lung cancer was responsible for 1.8 million deaths — 18% of cancer deaths — in 2020 alone.
See, Vice President of Oncology Clinical Development at Gilead, took a moment to walk us through some of the new innovations in breast cancer and the work underway at Gilead Oncology, where the vision is to help bring more life to people with cancer.
As Gilead maps out its next decade, including plans for a new Research Center in Foster City, we talked with Flavius about Gilead’s history of innovation and plans for the future.
Illumina has been included in the 2023 Bloomberg Gender-Equality Index for the fifth consecutive year. The distinguished index rates over 11,000 public companies and selects the top 500 committed to supporting gender equality in the workplace.
There’s new energy around connecting — whether among people or technologies — thanks to the not-so-distant pandemic lockdowns that reminded the world why relationships matter.
To see Anita Abu Bakar from the outside was to see the picture of confidence: a self-described extrovert, she was surrounded by friends, a onetime school leader who grew into a woman who loved her work as an investment banker in her native Malaysia.
The Festival of Genomics & Biodata 2023, held in London in January, is the largest event in the UK’s genomics events calendar. More than 4000 delegates from health care, academia, technology, and pharma came together to network and share the latest findings.
According to the Uganda AIDS Commission, approximately 1.4 million people in Uganda were living with HIV in 2020, up from 1.2 million a decade earlier.
Addressing disease resistance to antibiotics – known as antimicrobial resistance, or AMR – has emerged as a top priority of the 21st century, one that will require global partnership across many stakeholders to solve.
A decade ago, the evolution of immuno-oncology transformed the landscape of therapy for patients with many cancers. Although individual immunotherapies have helped to improve outcomes for patients.
According to the fifth annual “Writing Off the End of the Year” survey commissioned by Herbalife Nutrition, while 60% of Americans planned to break their healthy diets at the end of the year, almost half (46%) planned to make a New Year’s resolution.
Advancing women and minority-owned small businesses and entrepreneurs around the world. Small to mid-sized businesses power their local economies and...
Cascale shares insights regarding policy and regulation impacting the consumer goods industry, and highlights how it's supporting members prepare for...
